e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Acute critical care: novelties in critical care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
N-terminal pro-B-type natriuretic peptide in non-surgical critically ill patents
Xubin Huang (Guangzhou, China), Xubin Huang, Jun Zhang, Mian Zeng, Yanzhu Chen
Source:
International Congress 2015 – Acute critical care: novelties in critical care
Session:
Acute critical care: novelties in critical care
Session type:
Thematic Poster Session
Number:
2147
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Xubin Huang (Guangzhou, China), Xubin Huang, Jun Zhang, Mian Zeng, Yanzhu Chen. N-terminal pro-B-type natriuretic peptide in non-surgical critically ill patents. Eur Respir J 2015; 46: Suppl. 59, 2147
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Indications and pitfalls of high-flow nasal cannula (HFNC) outside the intensive care unit
Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Related content which might interest you:
LATE-BREAKING ABSTRACT: The evolution of procalcitonin as a prognostic factor in critically ill patients with sepsis
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Effect of body mass index on B-type natriuretic peptide levels in critically ill patients
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018
Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
The relationship between delayed anti-TB treatment and hospital mortality in critically ill patients
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis
Source: International Congress 2016 – Sepsis and ARDS: looking forward
Year: 2016
Steroid use in elderly critically ill COVID-19 patients
Source: Eur Respir J, 58 (4) 2100979; 10.1183/13993003.00979-2021
Year: 2021
Reduction in mitochondrial biogenesis balanced by a shift away from fat metabolism in critically ill patients
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014
Functional status of patients readmitted to ICU
Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations
Year: 2013
Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP
Source: Eur Respir J 2011; 37: 595-603
Year: 2011
The impact of bundle care on medical expenses reduction in critically-ill patients with blood stream infection
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Which tracheostomy in critically ill patients?
Source: Annual Congress 2008 - Tracheostomy in critically ill patients
Year: 2008
Why tracheostomy in critically ill patients?
Source: Annual Congress 2008 - Tracheostomy in critically ill patients
Year: 2008
Clinically important drug interactions with anti-infective agents in critically ill patients with respiratory disorders
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
The role of N-terminal pro B-type natriuretic peptide in predicting mortality of community acquired pneumonia
Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis
Year: 2019
Natriuretic peptide as a prognostic biomarker in septic shock in respiratory intensive care
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013
Does plasma NGAL help for prediction of acute kidney injury in sepsis patients?: A systematic review and meta-analysis
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Breath markers in critically ill patients
Source: Annual Congress 2004 - New tools and new concepts in respiratory monitoring
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept